Private Capital Management Inc. decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.3% during the second quarter, Holdings Channel reports. The fund owned 5,800 shares of the healthcare conglomerate’s stock after selling 1,050 shares during the period. UnitedHealth Group accounts for 1.2% of Private Capital Management Inc.’s portfolio, making the stock its 17th largest position. Private Capital Management Inc.’s holdings in UnitedHealth Group were worth $1,075,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Teachers Advisors LLC boosted its position in shares of UnitedHealth Group by 56.8% in the fourth quarter. Teachers Advisors LLC now owns 1,929,490 shares of the healthcare conglomerate’s stock worth $308,796,000 after buying an additional 698,955 shares during the last quarter. Kentucky Retirement Systems acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $11,054,000. Kentucky Retirement Systems Insurance Trust Fund acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $4,932,000. Searle & CO. acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $537,000. Finally, Wsfs Capital Management LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $1,728,000. Institutional investors and hedge funds own 86.37% of the company’s stock.

UnitedHealth Group Incorporated (UNH) traded up 0.26% during mid-day trading on Friday, reaching $193.07. 1,230,805 shares of the company traded hands. The firm has a market capitalization of $186.67 billion, a P/E ratio of 23.19 and a beta of 0.64. UnitedHealth Group Incorporated has a 12-month low of $132.39 and a 12-month high of $196.04. The company’s 50 day moving average price is $189.18 and its 200 day moving average price is $174.51.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.96 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Private Capital Management Inc. Sells 1,050 Shares of UnitedHealth Group Incorporated (NYSE:UNH)” was first published by Daily Political and is the property of of Daily Political. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/08/11/private-capital-management-inc-sells-1050-shares-of-unitedhealth-group-incorporated-nyseunh.html.

UNH has been the topic of a number of recent research reports. Mizuho increased their price target on shares of UnitedHealth Group from $178.00 to $200.00 and gave the company a “buy” rating in a research report on Tuesday, April 18th. Stifel Nicolaus reiterated a “buy” rating and set a $185.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 19th. Evercore ISI reiterated an “outperform” rating and set a $185.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 19th. Credit Suisse Group increased their price target on shares of UnitedHealth Group from $185.00 to $188.00 and gave the company an “outperform” rating in a research report on Wednesday, April 19th. Finally, Deutsche Bank AG reiterated a “buy” rating and set a $187.00 price target (up from $183.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. One research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $200.24.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the sale, the director now directly owns 75,735 shares in the company, valued at approximately $13,832,240.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The disclosure for this sale can be found here. Insiders have sold a total of 15,540 shares of company stock valued at $2,873,320 over the last 90 days. 0.89% of the stock is currently owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.